According to this complaint, investors were misled by Clover and its senior management about the fact that it was the subject of an investigation by the U.S. Department of Justice. Investors learned the truth about Clover on February 4, 2021, when a report published by Hindenburg Research stated that Clover has been under active investigation by the DOJ for issues ranging from marketing practices to kickbacks to undisclosed third-party deals. Prior to the merger, Clover did not reveal the existence of the DOJ inquiry. On this news, Clover shares fell $1.72 – or 12% – from a closing price of $13.95 on February 3, 2021 to a closing price of $12.23 on February 4, 2021.
Clover Health Investments, Corp.
Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to firstname.lastname@example.org.
There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.
We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at email@example.com.
If you choose to take no action, you can remain an absent class member.
Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.
The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
1800 Century Park East, Suite 600
Los Angeles, CA 90067